Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Aerobiology and pollution (41)
  • Allergen immunotherapy (81)
  • AllergoOncology (15)
  • Allergy asthma and a sport (4)
  • Allergy diagnosis (235)
  • Allied health and primary care (20)
  • Anaphylaxis (113)
  • Artificial Intelligence (12)
  • x Asthma (185)
  • Basic immunology (58)
  • x Biologicals (90)
  • Biomarkers (64)
  • Comparative veterinary allergology (1)
  • COVID19 (11)
  • Dermatology (125)
  • Drug allergy (172)
  • ENT (29)
  • Environmental allergy and climate change (31)
  • Eosinophilic esophagitis (21)
  • Epidemiology (66)
  • Epithelial cell biology (8)
  • Food allergy (195)
  • Genomics and proteomics (17)
  • Immune deficiencies and autoimmunity (80)
  • Immunomodulation and nutrition (13)
  • Infections (27)
  • Insect venom hypersensitivities (19)
  • Mastocytosis and mast cells (24)
  • Microbiome (9)
  • Occupational allergy (27)
  • Ocular allergy (5)
  • One Health (13)
  • Pediatrics (144)
  • Prevention (40)
  • Systems medicine (13)
Poster available until
  • Until platform closure (2)
Poster categories
  • e-Thematic Poster Session (18)
  • Thematic Poster Session (170)
keywords
Session Reference
  • L-TPS02 (14)
  • L-TPS07 (11)
  • L-TPS08 (1)
  • L-TPS09 (8)
  • L-TPS10 (12)
  • L-TPS16 (14)
  • L-TPS18 (2)
  • L-TPS19 (2)
  • L-TPS21 (1)
  • TPS06 (9)
  • TPS07 (11)
  • TPS08 (1)
  • TPS09 (5)
  • TPS17 (4)
  • TPS18 (9)
  • TPS19 (1)
  • TPS25 (1)
  • TPS28 (1)
  • TPS29 (16)
  • TPS30 (11)
  • TPS31 (15)
  • TPS51 (9)
  • TPS52 (5)
  • TPS55 (13)
  • TPS56 (16)
  • TPS57 (12)
  • TPS63 (1)
  • TPS67 (9)
  • TPS69 (3)
235 results
Thumbnail

D2.144 - Occupational Asthma due to garlic powder: a case report

Thumbnail

D2.145 - The utility of blood eosinophils, IgE and skin prick testing in paediatric asthma diagnosis

Thumbnail

D2.146 - Occupational Asthma due to Subtilisin: the power of specific inhalation challenge

Thumbnail

D2.147 - Comparison of clinical outcomes with Benralizumab in severe eosinophilic asthma: Switched and naïve patients

Thumbnail

D1.405 - Immunological imprinting of IgG response to RV VP1 in children of the MAS and PAPS birth cohorts

Thumbnail

000486 - Objective and Subjective Sleep Assessments in Patients With Atopic Dermatitis Treated With Dupilumab: Results From DUPISTAD, a Phase 4 Randomized Placebo-Controlled Study

Thumbnail

100455 - Ocrelizumab-associated secondary hypogammaglobulinemia and sever pneumonia: Case Report

Thumbnail

D1.159 - The successful resolve of nasal polyps in patient with dupilumab treatment

Thumbnail

D1.372 - Potential blood biomarkers of disease activity in patients with chronic spontaneous urticaria

Thumbnail

D1.375 - Ciclosporin for omalizumab-refractory CSU in a Paediatric population in Cork University Hospital: a case series

Thumbnail

D1.376 - Emerging inmunomodulatory agents for atopic dermatitis

Thumbnail

D1.377 - Berotralstat effectively controls a type 2 Hereditary Angioedema patient, refractory to other long-term prophylaxis treatments – Case report

Thumbnail

D1.378 - Evaluating the efficacy of dupilumab treatment for atopic dermatitis across geographic areas: A systematic review and meta-regression analysis

Thumbnail

D1.379 - AllergoOncology: Generation of Equinized Anti-PD-L1 mAbs with Specific Equine Constant Regions by MOE-PCR Ligation-Independent Cloning (LIC)

Thumbnail

D1.380 - Quicker EASI 75 or greater decline of DLQI - is it significant? Comparison of dupilumab treatment among children and adults in two centres in Cracow

Thumbnail

D1.383 - Nonimmediate hypersensitivity reaction to Lanadelumab in a patient with Hereditary Angioedema: a case report

Thumbnail

D1.384 - Long-term Prophylaxis with Lanadelumab in Hereditary and Acquired Angioedema: A Single-Center Retrospective-Prospective “Real-Life” Analysis

Thumbnail

D1.385 - Dupilumab Treatment Effects on Atopic Manifestations in Patients with Inborn Errors of Immunity

Thumbnail

D1.386 - Impact of dupilumab on allergen specific immunoglobulin E production

Thumbnail

D2.76 - When Eosinophilia Persists: Unmasking an Unexpected Diagnosis in a Dupilumab Treated Atopic Dermatitis Patient

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Current page 10
  • Page 11
  • Page 12
  • Next page Next
  • Last page Last
Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM